News

New chikungunya diagnostic assay proves quick, effective


 

FROM PLOS NEGLECTED TROPICAL DISEASES

References

A reverse transcription recombinase polymerase amplification (RT-RPA) assay was able to quickly and effectively identify chikungunya virus (CHIKV), according to a study published in PLOS Neglected Tropical Diseases.

Using chikungunya virus RNA samples, the RT-RPA assay detected down to 80 genome copies per reaction within 15 minutes, a time period four to six times faster than other molecular diagnostic techniques, such as reverse transcription-polymerase chain reaction (RT-PCR). In a sensitivity test involving all chikungunya serotypes and various alphaviruses, flaviviruses, and one phlebovirus, the RT-RPA assay identified all virus genotypes, with the only cross-reaction occurring with O’nyong’nyong virus.

CDC/Cynthia Goldsmith

In a test involving 58 plasma samples of suspected chikungunya fever from a trial in Thailand, two real-time RT-PCR tests identified 36 out of 58 samples (62%) as positive for chikungunya. The RT-RPA test successfully detected the virus in all 36 positive samples and did not detect the virus in any of the negative samples, giving a sensitivity and specificity of 100%.

“The CHIKV RPA assay presented here is a promising tool for CHIKV diagnostics at the point of need,” the investigators wrote. “Integration into a multimer or multiplex assay for simultaneous and differential detection of CHIKV, Dengue virus, and Zika virus, as well as an internal positive control would improve outbreak investigations, since the three viruses induce the same clinical picture upon infection and increasingly cocirculate in many parts of the world.”

Find the full study in PLOS Neglected Tropical Diseases (doi: 10.1371/journal.pntd.0004953).

lfranki@frontlinemedcom.com

Recommended Reading

Another infant with Zika-related birth defect born in the United States
MDedge Family Medicine
Zika’s not the only mosquito-borne virus to worry about
MDedge Family Medicine
Doctors urge Congress to pass Zika funding
MDedge Family Medicine
Case-control study points to Zika virus as cause of microcephaly
MDedge Family Medicine
Number of Zika-infected pregnancies jumps in states/D.C.
MDedge Family Medicine
Two novel DNA Zika virus vaccines set for human trials
MDedge Family Medicine
Zika cases in pregnant women hit new weekly high
MDedge Family Medicine
VIDEO: Consider chikungunya for unexplained seronegative arthritis
MDedge Family Medicine
Nonsexual secondary Zika virus case confirmed in Utah
MDedge Family Medicine
Congress sends Zika funding bill to President
MDedge Family Medicine